Cassava Sciences | PTIE - Beneficio Operativo

Precio De Mercado
1.24
Cambio Diario
0.01 0.81%
Mensual
-22.98%
Anual
-39.51%
Q2 Expectativa
1.27




Beneficio Operativo Cambio Fecha
Abbott USD 1.85B 399M 2026-03
Amgen USD 3.83B 130M 2026-03
Biogen USD 514.3M 128.8M 2026-03
Cara Therapeutics USD -5.94M 3.55M 2025-09
Cassava Sciences USD -13.55M 1.69M 2025-12
Eisai JPY 20.03B 6.36B 2025-12
Eli Lilly USD 9.78B 792M 2026-03
Geron USD -236K 10.55M 2026-03
J&J USD 6.62B 1.03B 2026-03
Merck USD -1.88B 8.12B 2026-03
Novartis USD 4.24B 171M 2026-03
Novavax USD 20.94M 100.32M 2025-12
Pfizer USD 4.99B 340M 2026-03
Roche Holding CHF 9.56B 3.8B 2025-12